Axsome Therapeutics (AXSM), (BNTX), HLTH Corporation (HLTH), (HOWL), …
The US Food and Drug Administration (FDA) has granted orphan drug status Intellia therapeutics‘ NTLA Lead asset NTLA-2002 for the treatment of hereditary angioedema (HAE).
Home » AXSM
The US Food and Drug Administration (FDA) has granted orphan drug status Intellia therapeutics‘ NTLA Lead asset NTLA-2002 for the treatment of hereditary angioedema (HAE).
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents